Poster session 1
Viral vectors

Programme

• • Poster Presentation
  • PP 159

  HIV-1 reverse transcriptase stability is associated with virus particle processing efficiency

  • Professor Chin-Tien Wang (Taipei City / TW)

   Viral vectors
• • Poster Presentation
  • PP 160

  Effects of Zika virus infection on the locomotor activity of Aedes aegypti and Aedes albopictus (Diptera: Culicidae) under laboratory conditions – preliminary data

  • Dr. Tamara Lima-Camara (São Paulo / BR)

   Viral vectors, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 161

  The phase-separation properties of the adeno-associated virus type 2 (AAV2) assembly-activating protein

  • Janine Vetter (Zurich / CH)

   Viral vectors
• • Poster Presentation
  • PP 162

  Potential for RNA recombination between an alphavirus-based self-amplifying mRNA vaccine and a wild-type alphavirus

  • Tessy Hick (Wageningen / NL)

   Vaccines, Viral vectors
• • Poster Presentation
  • PP 163

  Development and characterization of a reporter system to tackle novel post-transcriptional mechanisms involved in HIV-1 latency

  • Jakub Wadas (Kraków / PL)

   Viral vectors
• • Poster Presentation
  • PP 164

  Surveillance for viruses circulating in mosquitoes in Kangerlussuaq, Greenland

  • Mirjam Schilling (Addlestone / GB)

   Invertebrate viruses, Viral vectors
• • Poster Presentation
  • PP 165

  Determination of the tick microbiome of Ixodes ricinus ticks in the United Kingdom

  • Mirjam Schilling (Addlestone / GB)

   Invertebrate viruses, Viral vectors
• • Poster Presentation
  • PP 166

  Identification and characterization of major structural core proteins of Vaccinia Virus using cryo-electron microscopy

  • Julia Datler (Klosterneuburg / AT)

   Viral vectors
• • Poster Presentation
  • PP 167

  Distinguishable neutralizing Zika virus antibodies among dengue patients with prior exposure to the Japanese encephalitis virus

  • Dr. Gielenny Salem (Taichung / TW)

   Viral vectors
• • Poster Presentation
  • PP 168

  PRV-vectored subunit PCV2b and CSFV vaccine is safe and protects pigs against both porcine circovirus 2b and classical swine fever virus challenge

  • Professor Shafiqul Chowdhury (Baton Rouge, LA / US)

   Veterinary virology, Viral vectors
• • Poster Presentation
  • PP 169

  Improving stability of SARS-CoV-2 derived virus-like particles

  • Dr. Antonina Naskalska (Kraków / PL)

   Viral vectors
• • Poster Presentation
  • PP 170

  Species D human adenovirus uses CD46 as receptor

  • Katarina Danskog (Umeå / SE)

   Viral vectors
• • Poster Presentation
  • PP 171

  Non-infectious Mason-Pfizer monkey virus particles for studying late life cycle stages

  • Karolína Štrbová (Prague / CZ)

   Viral vectors
• • Poster Presentation
  • PP 172

  Virus-host interactions and prediction of putative hosts in Flavivirus and Coronaviridae

  • Phuoc Truong Nguyen (Helsinki / FI)

   Viral vectors
• • Poster Presentation
  • PP 173

  High-speed atomic force microscopy reveals real-time dynamics of influenza A virus transcription

  • Dr. Diego Carlero (Madrid / ES)

   Viral vectors